Vanda Pharmaceuticals Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Vanda Pharmaceuticals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 21.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much
Apr 05Vanda Pharmaceuticals' (NASDAQ:VNDA) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Feb 15Vanda Pharmaceuticals' Portfolio Likely Has Upside From 2024 Approvals, Underpinned By Cash
Feb 13Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) Low P/S No Reason For Excitement
Feb 10News Flash: One Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Analyst Has Been Trimming Their Revenue Forecasts
Nov 11One Forecaster Is Now More Bearish On Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Than They Used To Be
May 12Vanda Pharmaceuticals: What The Recent Partnership Entails
Oct 06Vanda Pharma, OliPass collaborate to develop oligonucleotide-based therapeutics
Sep 29Vanda Pharmaceuticals Q2 Earnings Preview
Aug 02Vanda Pharmaceuticals: Strong Pipeline Developments To Power Long-Term Upside
May 17Vanda: A Dual Growth And Value Player
Apr 11In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vanda Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 193 | 3 | -88 | 13 | N/A |
9/30/2023 | 212 | 12 | 26 | 26 | N/A |
6/30/2023 | 238 | 15 | 40 | 41 | N/A |
3/31/2023 | 257 | 16 | 59 | 60 | N/A |
12/31/2022 | 254 | 6 | 31 | 32 | N/A |
9/30/2022 | 258 | 6 | 49 | 49 | N/A |
6/30/2022 | 263 | 11 | 45 | 46 | N/A |
3/31/2022 | 266 | 18 | 59 | 59 | N/A |
12/31/2021 | 269 | 33 | 64 | 64 | N/A |
9/30/2021 | 268 | 34 | 56 | 57 | N/A |
6/30/2021 | 259 | 32 | 55 | 57 | N/A |
3/31/2021 | 253 | 32 | 60 | 62 | N/A |
12/31/2020 | 248 | 23 | 50 | 52 | N/A |
9/30/2020 | 241 | 19 | 41 | 42 | N/A |
6/30/2020 | 241 | 114 | 38 | 39 | N/A |
3/31/2020 | 237 | 117 | 34 | 35 | N/A |
12/31/2019 | 227 | 116 | 45 | 46 | N/A |
9/30/2019 | 219 | 122 | 50 | 51 | N/A |
6/30/2019 | 209 | 28 | 53 | 54 | N/A |
3/31/2019 | 197 | 22 | 12 | 38 | N/A |
12/31/2018 | 193 | 25 | 5 | 30 | N/A |
9/30/2018 | 184 | 13 | -7 | 18 | N/A |
6/30/2018 | 177 | 1 | -14 | 12 | N/A |
3/31/2018 | 171 | -5 | 4 | 5 | N/A |
12/31/2017 | 165 | -16 | -4 | -2 | N/A |
9/30/2017 | 159 | -14 | N/A | -7 | N/A |
6/30/2017 | 156 | -10 | N/A | -8 | N/A |
3/31/2017 | 150 | -13 | N/A | -9 | N/A |
12/31/2016 | 146 | -18 | N/A | -8 | N/A |
9/30/2016 | 140 | -32 | N/A | -7 | N/A |
6/30/2016 | 129 | -41 | N/A | -13 | N/A |
3/31/2016 | 121 | -42 | N/A | 2 | N/A |
12/31/2015 | 110 | -40 | N/A | 12 | N/A |
9/30/2015 | 93 | 45 | N/A | -1 | N/A |
6/30/2015 | 80 | 53 | N/A | -3 | N/A |
3/31/2015 | 63 | 36 | N/A | -52 | N/A |
12/31/2014 | 50 | 20 | N/A | -82 | N/A |
9/30/2014 | 44 | -57 | N/A | -80 | N/A |
6/30/2014 | 37 | -61 | N/A | -83 | N/A |
3/31/2014 | 35 | -43 | N/A | -54 | N/A |
12/31/2013 | 34 | -21 | N/A | -40 | N/A |
9/30/2013 | 33 | -20 | N/A | -41 | N/A |
6/30/2013 | 33 | -20 | N/A | -41 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if VNDA's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if VNDA's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if VNDA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if VNDA's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if VNDA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VNDA's Return on Equity is forecast to be high in 3 years time